Total Payments
$11,984
2024 Payments
$3,429
Companies
15
Transactions
93
Medicare Patients
3,754
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$5,105 (42.6%)
Consulting$3,830 (32.0%)
Travel$3,049 (25.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,105 | 84 | 42.6% |
| Consulting Fee | $3,830 | 2 | 32.0% |
| Travel and Lodging | $3,049 | 7 | 25.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EyePoint Pharmaceuticals US, Inc. | $4,314 | 10 | $0 (2024) |
| Genentech USA, Inc. | $3,871 | 10 | $0 (2024) |
| Alcon Vision LLC | $1,236 | 13 | $0 (2022) |
| Alcon Laboratories Inc | $679.44 | 8 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $636.23 | 14 | $0 (2024) |
| ABBVIE INC. | $267.57 | 14 | $0 (2024) |
| Alimera Sciences, Inc. | $209.16 | 8 | $0 (2024) |
| Astellas Pharma US Inc | $150.29 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $126.57 | 1 | $0 (2018) |
| Ocular Therapeutix, Inc. | $123.60 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,429 | 35 | EyePoint Pharmaceuticals US, Inc. ($2,467) |
| 2023 | $574.81 | 19 | Regeneron Healthcare Solutions, Inc. ($298.94) |
| 2022 | $6,040 | 17 | Genentech USA, Inc. ($3,749) |
| 2021 | $20.60 | 1 | Apellis Pharmaceuticals, Inc. ($20.60) |
| 2020 | $35.96 | 1 | Alcon Vision LLC ($35.96) |
| 2019 | $1,077 | 11 | Alcon Vision LLC ($1,077) |
| 2018 | $806.01 | 9 | Alcon Laboratories Inc ($679.44) |
All Payment Transactions
93 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: EYE CARE | ||||||
| 11/14/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/08/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/07/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 10/29/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | Cash or cash equivalent | $141.97 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/29/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | Cash or cash equivalent | $32.86 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $953.99 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $408.21 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Travel and Lodging | In-kind items and services | $408.21 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $305.99 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/26/2024 | EyePoint Pharmaceuticals US, Inc. | EYP-1901 (Drug) | Food and Beverage | In-kind items and services | $215.50 | General |
| Category: Wet Age Related Macular Degeneration (wAMD) | ||||||
| 10/23/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: EYE CARE | ||||||
| 10/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/08/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: EYE CARE | ||||||
| 09/30/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $33.17 | General |
| Category: EYE CARE | ||||||
| 09/09/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Ophthalmology | ||||||
| 08/19/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: EYE CARE | ||||||
| 07/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/27/2024 | Sandoz Inc. | Cimerli (Biological) | Food and Beverage | In-kind items and services | $35.58 | General |
| Category: Ophthalmology | ||||||
| 06/25/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/13/2024 | Genentech USA, Inc. | Lucentis (Biological), Vabysmo | Food and Beverage | In-kind items and services | $26.06 | General |
| Category: Ophthalmology | ||||||
| 06/10/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 06/06/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Ophthalmology | ||||||
| 06/04/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: EYE CARE | ||||||
| 05/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 3,292 | 10,561 | $7.2M | $1.7M |
| 2022 | 10 | 462 | 676 | $457,240 | $102,500 |
Total Patients
3,754
Total Services
11,237
Medicare Billing
$1.8M
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 177 | 1,366 | $3.4M | $935,685 | 27.4% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 58 | 950 | $950,000 | $179,347 | 18.9% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 647 | 1,511 | $553,026 | $162,698 | 29.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 271 | 962 | $566,210 | $101,733 | 18.0% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 14 | 1,920 | $240,000 | $55,631 | 23.2% |
| 92134 | Imaging of retina | Office | 2023 | 674 | 1,533 | $689,850 | $54,903 | 8.0% |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | Office | 2023 | 14 | 190 | $190,000 | $40,974 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 290 | 290 | $136,300 | $36,761 | 27.0% |
| J3590 | Unclassified biologics | Office | 2023 | 12 | 16 | $110,500 | $36,036 | 32.6% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2023 | 532 | 1,026 | $117,990 | $13,805 | 11.7% |
| 92250 | Photography of the retina | Office | 2023 | 232 | 283 | $54,902 | $8,903 | 16.2% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2023 | 51 | 52 | $19,396 | $6,475 | 33.4% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 39 | 82 | $57,728 | $5,864 | 10.2% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 154 | 207 | $25,875 | $4,378 | 16.9% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 53 | 95 | $24,983 | $3,976 | 15.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 26 | $9,412 | $2,835 | 30.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 29 | 33 | $8,547 | $2,644 | 30.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 19 | 19 | $8,189 | $2,321 | 28.3% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 25 | 72 | $179,000 | $49,650 | 27.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 13 | 90 | $90,000 | $18,364 | 20.4% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 84 | 108 | $39,528 | $12,031 | 30.4% |
| 67028 | Injection of drug into eye | Office | 2022 | 48 | 67 | $43,150 | $6,970 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 46 | 46 | $21,620 | $6,626 | 30.6% |
| 92134 | Imaging of retina | Office | 2022 | 111 | 137 | $60,200 | $4,920 | 8.2% |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | Office | 2022 | 82 | 96 | $11,040 | $1,315 | 11.9% |
About Dr. Tamara Lenis, M.D
Dr. Tamara Lenis, M.D is a Ophthalmology healthcare provider based in Teaneck, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2013. The National Provider Identifier (NPI) number assigned to this provider is 1982947842.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tamara Lenis, M.D has received a total of $11,984 in payments from pharmaceutical and medical device companies, with $3,429 received in 2024. These payments were reported across 93 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($5,105).
As a Medicare-enrolled provider, Lenis has provided services to 3,754 Medicare beneficiaries, totaling 11,237 services with total Medicare billing of $1.8M. Data is available for 2 years (2022–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Retina Specialist
- Location Teaneck, NJ
- Active Since 03/28/2013
- Last Updated 02/27/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1982947842
Products in Payments
- SUSVIMO (Drug) $3,743
- EYP-1901 (Drug) $2,467
- YUTIQ (Drug) $1,892
- AcrySof (Device) $1,295
- EYLEA HD (Biological) $470.64
- EYLEA (Biological) $269.51
- OZURDEX (Drug) $267.57
- ILUVIEN (Drug) $163.56
- PanOptix (Device) $137.93
- Izervay (Drug) $135.42
- DEXTENZA (Drug) $123.60
- rocklatan (Drug) $123.06
- VABYSMO (Drug) $107.37
- Vabysmo (Drug) $80.00
- XIPERE (Drug) $55.02
- Syfovre (Drug) $54.22
- Lucentis (Biological) $41.95
- Cimerli (Biological) $35.58
- LenSx (Device) $24.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Teaneck
Luis Gonzalez Gonzalez, M.d., M.p.h, M.D., M.P.H
Ophthalmology — Payments: $59,169
Ophthalmology $59,169
Ronald Glassman, Md, MD
Ophthalmology — Payments: $21,202
Ophthalmology $21,202
Dr. Andrew Brown, M.d, M.D
Ophthalmology — Payments: $4,699
Ophthalmology $4,699
Dr. Robert Brown, M.d, M.D
Ophthalmology — Payments: $4,484
Ophthalmology $4,484
Lawrence Najarian, Md, MD
Ophthalmology — Payments: $2,986
Ophthalmology $2,986
Louis Angioletti, M.d, M.D
Ophthalmology — Payments: $1,729
Ophthalmology $1,729